TW200616628A - Pharmaceutical composition for xerophthalmia and xerostomia treatment - Google Patents

Pharmaceutical composition for xerophthalmia and xerostomia treatment

Info

Publication number: TW200616628A
Authority: TW; Taiwan
Prior art keywords: xerophthalmia; pharmaceutical composition; xerostomia; xerostomia treatment; treatment
Prior art date: 2004-10-05

Application number

TW094134706A

Other languages

English (en)

Inventor

Yohei Okada

Ken Ikeda

Fumikazu Wanibuchi

Keiichi Yoshihara

Hiromu Kondo

Original Assignee

Astellas Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-05

Filing date

2005-10-04

Publication date

2006-06-01

2005-10-04 Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc

2006-06-01 Publication of TW200616628A publication Critical patent/TW200616628A/zh

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

TW094134706A 2004-10-05 2005-10-04 Pharmaceutical composition for xerophthalmia and xerostomia treatment TW200616628A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2004292611		2004-10-05

Publications (1)

Publication Number	Publication Date
TW200616628A true TW200616628A (en)	2006-06-01

Family

ID=36142669

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW094134706A TW200616628A (en)	2004-10-05	2005-10-04	Pharmaceutical composition for xerophthalmia and xerostomia treatment

Country Status (15)

Country	Link
US (2)	US20070105934A1 (zh)
EP (1)	EP1712230A1 (zh)
JP (1)	JPWO2006038596A1 (zh)
KR (1)	KR20070061578A (zh)
CN (1)	CN101031297A (zh)
AU (1)	AU2005290532A1 (zh)
BR (1)	BRPI0516468A (zh)
CA (1)	CA2582615A1 (zh)
IL (1)	IL182124A0 (zh)
MX (1)	MX2007003994A (zh)
NO (1)	NO20072328L (zh)
RU (1)	RU2007116944A (zh)
TW (1)	TW200616628A (zh)
WO (1)	WO2006038596A1 (zh)
ZA (1)	ZA200702784B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPWO2007013661A1 (ja) *	2005-07-26	2009-02-12	千寿製薬株式会社	眼科用経皮吸収型製剤
US10338203B2 (en)	2011-09-09	2019-07-02	Siemens Medical Solutions Usa, Inc.	Classification preprocessing in medical ultrasound shear wave imaging
JP6526475B2 (ja) *	2015-04-30	2019-06-05	サンスター株式会社	経皮唾液腺投与用の唾液分泌促進剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2683783B2 (ja) *	1992-07-10	1997-12-03	雪印乳業株式会社	シェーグレン症候群治療剤
KR100355130B1 (ko) *	1992-09-18	2003-01-30	야마노우치세이야쿠 가부시키가이샤	하이드로겔서방성정제
JPH07126163A (ja) *	1993-10-08	1995-05-16	Theratech Inc	制御放出性ピロカルピン送達システム
US6528529B1 (en) *	1998-03-31	2003-03-04	Acadia Pharmaceuticals Inc.	Compounds with activity on muscarinic receptors
US20020142033A1 (en) *	1998-05-05	2002-10-03	Gupta Suneel K.	Method for treating incontinence
US20020028240A1 (en) *	2000-04-17	2002-03-07	Toyohiro Sawada	Timed-release compression-coated solid composition for oral administration
JP2003063964A (ja) *	2001-08-28	2003-03-05	Senju Pharmaceut Co Ltd	ドライアイまたはドライアイを伴なう疾病の予防治療剤

2005
- 2005-10-04 AU AU2005290532A patent/AU2005290532A1/en not_active Abandoned
- 2005-10-04 TW TW094134706A patent/TW200616628A/zh unknown
- 2005-10-04 JP JP2006539287A patent/JPWO2006038596A1/ja not_active Withdrawn
- 2005-10-04 MX MX2007003994A patent/MX2007003994A/es not_active Application Discontinuation
- 2005-10-04 EP EP05790491A patent/EP1712230A1/en not_active Withdrawn
- 2005-10-04 RU RU2007116944/15A patent/RU2007116944A/ru not_active Application Discontinuation
- 2005-10-04 ZA ZA200702784A patent/ZA200702784B/xx unknown
- 2005-10-04 CA CA002582615A patent/CA2582615A1/en not_active Abandoned
- 2005-10-04 WO PCT/JP2005/018310 patent/WO2006038596A1/ja active Application Filing
- 2005-10-04 US US10/578,682 patent/US20070105934A1/en not_active Abandoned
- 2005-10-04 KR KR1020077010162A patent/KR20070061578A/ko not_active Application Discontinuation
- 2005-10-04 CN CNA2005800329427A patent/CN101031297A/zh active Pending
- 2005-10-04 BR BRPI0516468-0A patent/BRPI0516468A/pt not_active IP Right Cessation
2007
- 2007-03-22 IL IL182124A patent/IL182124A0/en unknown
- 2007-05-04 NO NO20072328A patent/NO20072328L/no not_active Application Discontinuation
- 2007-09-26 US US11/861,725 patent/US20080131511A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ZA200702784B (en)	2008-09-25
BRPI0516468A (pt)	2008-09-09
NO20072328L (no)	2007-06-29
RU2007116944A (ru)	2008-11-20
KR20070061578A (ko)	2007-06-13
AU2005290532A1 (en)	2006-04-13
MX2007003994A (es)	2007-06-15
US20080131511A1 (en)	2008-06-05
US20070105934A1 (en)	2007-05-10
CA2582615A1 (en)	2006-04-13
JPWO2006038596A1 (ja)	2008-05-15
EP1712230A1 (en)	2006-10-18
CN101031297A (zh)	2007-09-05
WO2006038596A1 (ja)	2006-04-13
IL182124A0 (en)	2007-07-24

Publication	Publication Date	Title
GEP20125565B (en)	2012-07-10	Lactam compounds and their pharmaceutical use
UA95975C2 (ru)	2011-09-26	N-метиламинометилизоиндольные соединения, композиции, содержащие их, и способы их применения
HK1076605A1 (en)	2006-01-20	Formulations
TW200621737A (en)	2006-07-01	2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
TW200626132A (en)	2006-08-01	Topical nepafenac formulations
GB0625648D0 (en)	2007-01-31	Compounds
MX2009007104A (es)	2009-09-18	Derivados de oxindol sustituido y su uso como ligandos del receptor de vasopresina.
TW200716546A (en)	2007-05-01	Oxindole compounds and their uses as therapeutic agents
MA29662B1 (fr)	2008-08-01	Compositions pour l'apport de medicaments hautement solubles dans l'eau
JO2701B1 (en)	2013-03-03	Vehicles
GEP20074197B (en)	2007-09-10	5ht2c receptor modulators
MY144992A (en)	2011-12-15	Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
TW200611695A (en)	2006-04-16	Pyrrolopyridine derivatives
GEP20084452B (en)	2008-08-10	Sulfonamide derivatives for the treatment of diseases
UA93709C2 (ru)	2011-03-10	12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
WO2005002515A3 (en)	2005-07-14	Delivery of therapeutic compounds to the brain and other tissues
MX2009007337A (es)	2009-07-15	Indazoles sustituidos con 5-piridinona.
TW200621244A (en)	2006-07-01	Modulators of muscarinic receptors
MX2007006382A (es)	2007-07-11	Moduladores de receptores muscarinicos.
GB2446341A (en)	2008-08-06	Method and system for transdermal drug delivery
TW200531686A (en)	2005-10-01	Pharmaceutical compositions
UA91694C2 (ru)	2010-08-25	Применение эмодепсида и pf1022a для предотвращения вертикальных эндопаразитарных инфекций
TW200616628A (en)	2006-06-01	Pharmaceutical composition for xerophthalmia and xerostomia treatment
MXPA05003718A (es)	2005-09-30	Compuestos x-nitro, sus composiciones farmaceuticas y sus usos.
MX2007004461A (es)	2007-07-11	Composiciones farmaceuticas a base de antagonistas de nk2 para uso pediatrico.